Research ArticleCancer

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

See allHide authors and affiliations

Science Signaling  09 Oct 2018:
Vol. 11, Issue 551, eaat9773
DOI: 10.1126/scisignal.aat9773

Article Information

vol. 11 no. 551

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received April 24, 2018
  • Accepted September 7, 2018
  • .

Author Information

Altmetric

Article usage

Article usage: October 2018 to October 2020

AbstractFullPdf
Oct 201819688661409
Nov 20184279657
Dec 20182284730
Jan 20191406628
Feb 20191233324
Mar 20191434530
Apr 20191384325
May 20191272314
Jun 2019982828
Jul 2019933016
Aug 20191283825
Sep 20191674622
Oct 20196211447
Nov 20191213260
Dec 20191617269
Jan 20201217537
Feb 20201013142
Mar 2020311145
Apr 202069153
May 202059768
Jun 2020910462
Jul 2020139935
Aug 202077731
Sep 202098850
Oct 202057228

Stay Connected to Science Signaling

Navigate This Article